Minetta Liu, MD, discusses the limitations of radiology in the treatment of patients with metastatic breast cancer.
Minetta Liu, MD, breast cancer specialist, Mayo Clinic, Rochester, Minnesota, discusses the limitations of radiology in the treatment of patients with metastatic breast cancer.
Liu says that the key in metastatic breast cancer is trying to stay ahead and determine the right time to change therapy. Currently, the gold standard for measuring this is by using imaging, such as CAT scans, MRIs, and ultrasounds.
However, Liu says, it is difficult for a radiologist to measure these tumors in a reproducibleway. A study in several solid tumors found a variability of 15% when separate radiologists were asked to look at identical images. Surprisingly, Liu says, the variation was even higher when the same radiologist looked at the same picture just one week later.
Liu says that a better, more reliable method must be determined. Counting circulating tumorcells (CTCs) are more reliable and reproducible and the variation is only on the order of 1% to 5%.
Although no test is perfect, having multiple, reliable tools would help physicians to measure the progression of metastatic breast cancer, Liu says.
Clinical Pearls
Batalini Explores Role of UGT1A1 in Patients Treated With Sacituzumab Govitecan for HR+ MBC
April 22nd 2024During a Community Case Forum live event in partnership with The Arizona Clinical Oncology Society, Felipe Batalini, MD, discussed the TROPiCS-02 trial of sacituzumab govitecan and the impact of the UGT1A1 status on adverse event frequency.
Read More
Breast Cancer Leans into the Decade of Antibody-Drug Conjugates, Experts Discuss
September 25th 2020In season 1, episode 3 of Targeted Talks, the importance of precision medicine in breast cancer, and how that vitally differs in community oncology compared with academic settings, is the topic of discussion.
Listen